YOLFTbeta
PR

Famon Awal Bros Sedaya

PRAY · JK · Healthcare / Medical Care Facilities

715.00IDR+35.00 (+5.15%)

Price History

Full chart

Market Stats

Previous Close680.00
Open680.00
Day Range680.00 – 715.00
52-Week Range535.00 – 980.00
Volume24.70K
Market Cap10.82T
P/E (TTM)56.61
Forward P/E0.00
EPS13.69
Dividend Yield0.00%
Beta0.35
50-Day Avg748.90
200-Day Avg753.78

About

PT Famon Awal Bros Sedaya Tbk operates a network of hospitals in Indonesia. The company offers mother and child center, heart and vascular center, trauma center, cancer center, urology center, brain and neurocenter, eye center, and sports clinic, and orthopedic center. It also provides other health services such as clinical laboratories, homecare, and medical evacuation, as well as other healthcare services. PT Famon Awal Bros Sedaya Tbk was founded in 1997 and is based in Kemayoran, Indonesia.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOEngineer Arfan Awaloeddin
  • Employees7.35K
  • HeadquartersGraha Cempaka Mas Blok D/5-6, Kemayoran, Indonesia, 10640, Indonesia
  • Websitehttps://primayahospital.com

Leadership

  • Engineer Arfan AwaloeddinPresident Director
  • Yoshen Danun M.B.A.Finance Director & Director
  • Nada PradiptaHead of Internal Audit · b. 1987
  • Mesri SabrianaCorporate Secretary

Financials

Income Statement

Currency: IDR2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.01T1.34T1.83T1.52T1.84T2.10T2.44T
Growth (%)-+31.80%+36.50%-16.61%+20.79%+14.34%+15.87%
Cost of Revenue690.44B778.41B1.04T1.14T1.32T1.50T1.76T
Gross Profit324.54B559.34B785.88B383.72B519.46B599.29B676.48B
Gross Margin31.97%41.81%43.04%25.20%28.24%28.50%27.76%
Operating Expense155.42B185.11B271.36B320.27B315.04B338.67B418.44B
Operating Income169.11B374.23B514.53B63.45B204.42B260.62B258.04B
Operating Margin16.66%27.97%28.18%4.17%11.11%12.39%10.59%
EBITDA251.96B482.18B644.01B251.37B443.01B555.45B528.94B
EBITDA Margin24.82%36.04%35.27%16.51%24.09%26.41%21.71%
Net Income122.20B282.21B325.96B62.50B216.97B201.44B211.43B
Net Income Margin12.04%21.10%17.85%4.10%11.80%9.58%8.68%
Interest Expense37.16B46.95B64.48B72.08B81.11B72.63B80.44B
Interest Expense % of Total Revenue3.66%3.51%3.53%4.73%4.41%3.45%3.30%

Balance Sheet

Currency: IDR2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.91T2.41T3.12T3.96T4.70T5.07T6.15T
Total Liabilities727.67B928.02B1.27T1.25T1.77T1.94T2.68T
Total Equity1.10T1.39T1.73T2.59T2.80T3.01T3.23T
Cash210.31B312.23B570.51B979.66B1.03T894.76B680.87B
Total Debt478.96B580.96B889.68B895.60B1.28T1.43T1.93T
Net Debt268.65B268.73B319.17B-84.06B252.54B534.26B1.25T

Cash Flow

Currency: IDR2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow117.66B304.24B479.59B173.13B266.00B309.33B460.60B
Investing Cash Flow-160.54B-286.09B-459.98B-560.42B-509.51B-591.03B-890.11B
Financing Cash Flow94.56B83.77B238.67B796.45B289.45B150.86B215.63B
Capital Expenditure173.41B287.52B462.64B444.25B537.79B616.30B863.82B
Free Cash Flow-55.76B16.72B16.95B-271.23B-271.79B-306.97B-403.22B
Dividends Paid---100.39B---
FCF to OCF-47.39%5.49%3.53%-156.66%-102.18%-99.24%-87.54%
Dividend Paid to FCF----37.02%---

Earnings

Report DateMar 31, 2023Jun 30, 2023
EPS Estimate--
EPS Actual6.601.54
Surprise--
Timing--

Key Statistics & Ratios

Market Cap10.82T
Enterprise Value12.03T
Trailing P/E56.61
Forward P/E0.00
Price / Sales3.91
Price / Book3.22
EPS13.69
Book Value235.79
Revenue (TTM)2.77T
Gross Profit (TTM)708.17B
EBITDA582.23B
Profit Margin6.68%
Operating Margin8.83%
Return on Equity5.46%
Return on Assets2.99%
Shares Outstanding13.96B
Shares Float1.14B
Beta0.35
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%